Trial Profile
An Open-Label, Phase I, Single Dose Study of the Pharmacokinetics, Mass Balance and Disposition of Intravenously Administered 14C-Methylnaltrexone in Normal, Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Progenics Pharmaceuticals
- 09 Jun 2011 New trial record